tirzepatide for the treatment of obstructive sleep apnea and obesity Why is Zepbound used Apnea? Zepbound® (tirzepatide) is approved for obstructive sleep (OSA) because it targets one most important underlying causes of the condition: obesity. OSA Breakthrough Treatment for Obstructive Sleep

Adequate hydration softens stool naturally and helps osmotic laxatives work more effectively

This helps you with medical bills after you pay a portion of the amount, with the full amount you pay dependent on your income

In addition to helping you feel fuller, GLP-1 agonists slow the rate at which food empties from your stomach, which delays the usual hormonal signals to your brain indicating that you need to eat, says Daniel J

Diarrhoea typically occurs during the first 48 weeks of treatment or following dose increases

However, practical experience suggests avoiding a large meal immediately before or after injection

Essential vitamins and minerals come from food